XPOVIO® is the first XPO1 inhibitor approved in Taiwan for the treatment of adult patients with relapsed/refractory multiple myeloma (R/R MM).
CANGZHOU,China,Feb. 13,2025-- A news report from xinhuanet: The Year of the Snake ushers in an energetic Spring Festival in Cangzhou,Hebei Province. Locals and tourists alike are reveling in the festi
The Only Forbes-Starred Hotel in Xiamen XIAMEN,China,Feb. 13,2025--Conrad Xiamen proudly announces its Four-Star recognition in the 2025 Forbes Travel Guide,making it the only hotel in Xiamen to recei
BEIJING,Feb. 13,2025-- As DeepSeek\'s cutting-edge technology rapidly expands across industries,Mafengwo announced the integration of its self-developed AI application with the DeepSeek large language
HONG KONG,Feb. 12,2025-- Hong Kong Airlines is pleased to announce the latest development of its network expansion,with the introduction of a new direct service to Sydney,Australia,set to commence on
PORT VILA,Vanuatu,Feb. 10,2025-- Vantage Markets is excited to announce its participation as a Titanium Sponsor at the highly anticipated Money Expo Mexico 2025,taking place on February 26-27 in Mexi
